Theravance Biopharma (TBPH) Prices 5.5M Share Common Offering at $27/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Pre-Open Stock Movers 02/11: (S) (AMKR) (TMUS) Higher; (YAYO) (CODX) (UAA) Lower (more...)
February 11, 2020 9:22 AM ESTToday's Pre-Open Stock Movers
Sprint (NYSE: S) 72.7% HIGHER; T-Mobile US, Inc. (NASDAQ:... More
After-Hours Stock Movers 2/10: (AMKR) (FLDM) (RNG) Higher; (YAYO) (LOGC) (WORK) Lower (more...)
February 10, 2020 6:01 PM ESTYayYo, Inc. (NASDAQ: YAYO) 45% LOWER; today announced its intention to voluntarily delist its common stock from the NASDAQ Stock Market (NASDAQ) effective on February 20, 2020. The Company expects that its common stock will be approved for quotation on the OTCQB from and after that date. The Company has elected to effect the voluntary delisting of its common stock after discussions with NASDAQs staff and based on the determination of the Companys board of directors that voluntarily delisting the common stock from the NASDAQ is in the best... More
Theravance Biopharma (TBPH) to Offer $150M in Common Stock
February 10, 2020 4:25 PM ESTTheravance Biopharma, Inc. (NASDAQ: TBPH) intends to offer $150.0 million of ordinary shares in an underwritten public offering. Theravance Biopharma also intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of additional ordinary shares. The offering is subject... More
